Koers OncoVista Innovative Therapies, Inc. Other OTC
Aandelen
OVIT
US68232J1051
Biotechnologie & Medisch Onderzoek
Omzet 2013 | - | Omzet 2014 | - | Marktkapitalisatie | 1,3 mln. 1,21 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2013 | -1 mln. -934K | Nettowinst (verlies) 2014 | -2 mln. -1,87 mln. | EV/omzet 2013 | - |
Nettoliquiditeiten 2013 | 44,9K 41,95K | Nettoschuld 2014 | 196K 183K | EV/omzet 2014 | - |
K/w-verhouding 2013 |
-0,75
x | K/w-verhouding 2014 |
-0,51
x | Werknemers | - |
Dividendrendement 2013 * |
-
| Dividendrendement 2014 |
-
| Vrij verhandelbaar | 100% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Chief Executive Officer | 74 | 16-08-07 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Chief Executive Officer | 74 | 16-08-07 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+40,80% | 53,67 mld. | |
-8,05% | 38,76 mld. | |
+35,79% | 38,86 mld. | |
-8,98% | 27,27 mld. | |
+10,69% | 25,91 mld. | |
-16,21% | 20,29 mld. | |
+31,00% | 12,78 mld. | |
+28,51% | 12,18 mld. | |
-1,67% | 11,96 mld. |